EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Urinary Proteomics and Precision Medicine for Chronic Kidney Disease: Current Status and Future Perspectives

Frederik Persson iD, Peter Rossing

PROTEOMICS – Clinical Applications · 2019-03 · 13 (2)

DOI: 10.1002/prca.201800176 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PROTEOMICS – Clinical Applications, online erschienen am 22.01.2019. Verfasst von Frederik Persson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center Copenhagen, Niels Steensensvej 1, DK-2820, Gentofte, Denmark. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Novo Nordisk Foundation, European Union Seventh Framework Programme, Novo Nordisk Foundation Center for Basic Metabolic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precision medicine is since long an ongoing refinement of classical medicine, integrating improved and more detailed pathophysiological understanding with rapid technological advances. In the heterogenous area of chronic kidney disease there seems to be a high potential for the improvement in treatment and prognosis for several causes, with new technologies under development, that are yet to be introduced in clinical practice. As in other medical disciplines, investigation of abundant peptide patterns (proteomics) has gained recent interest. Especially relevant for kidney disease, urinary proteomics may provide both improved diagnosis and, as reviewed here, also holds promise for personalized treatment in the future. So far, capillary electrophoresis coupled to mass spectrometry (CE‐MS) is the most widely applied technique, and in addition to several cross‐sectional and cohort studies, there is even an ongoing randomized controlled trial that will soon report on the concept used as a method of personalizing treatment. In addition, there is hope that urinary proteomics can turn into a “liquid biopsy,” replacing the invasive diagnostic procedure. The next couple of years will provide more answers on the topic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HumansPatient SelectionPeptidesPrecision MedicineProteomicsRenal Insufficiency, ChronicTreatment Outcome

Stichwörter der Autor:innen

albuminuriachronic kidney diseasediabetesglomerular filtrationurinary proteomics

Substanzen

Peptides

Autor:innen und Institutionen

  • Steno Diabetes Center Copenhagen, Niels Steensensvej 1, DK-2820, Gentofte, Denmark.
  • Institute of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, DK-2200, Copenhagen, Denmark.

ORCID-Profile: Frederik Persson

Förderung

  • Novo Nordisk Foundation
  • European Union Seventh Framework Programme
  • Novo Nordisk Foundation Center for Basic Metabolic Research
  • Seventh Framework Programme

Zitieren

APA

Persson, F., & Rossing, P. (2019). Urinary Proteomics and Precision Medicine for Chronic Kidney Disease: Current Status and Future Perspectives. PROTEOMICS – Clinical Applications, 13(2). https://doi.org/10.1002/prca.201800176

Vancouver

Persson F, Rossing P. Urinary Proteomics and Precision Medicine for Chronic Kidney Disease: Current Status and Future Perspectives. PROTEOMICS – Clinical Applications. 2019;13(2). doi:10.1002/prca.201800176

BibTeX
@article{Persson2019,
  author = {Persson, Frederik and Rossing, Peter},
  title = {Urinary Proteomics and Precision Medicine for Chronic Kidney Disease: Current Status and Future Perspectives},
  journal = {PROTEOMICS – Clinical Applications},
  year = {2019},
  volume = {13},
  number = {2},
  doi = {10.1002/prca.201800176}
}
Kostenlos starten →